BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 27862622)

  • 21. 18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data.
    Barber TW; Duong CP; Leong T; Bressel M; Drummond EG; Hicks RJ
    J Nucl Med; 2012 Jun; 53(6):864-71. PubMed ID: 22582047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma.
    Bütof R; Hofheinz F; Zöphel K; Stadelmann T; Schmollack J; Jentsch C; Löck S; Kotzerke J; Baumann M; van den Hoff J
    J Nucl Med; 2015 Aug; 56(8):1150-6. PubMed ID: 26089549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utility of FDG-PET in the preoperative staging of esophageal cancer.
    Gananadha S; Hazebroek EJ; Leibman S; Berry H; Osgood L; Shon IH; Pavlakis N; Marx G; Smith GS
    Dis Esophagus; 2008; 21(5):389-94. PubMed ID: 19125791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Additional value of EUS in oesophageal cancer patients staged N0 on PET/CT: validation of a prognostic model.
    Foley KG; Fielding P; Lewis WG; Roberts SA
    Surg Endosc; 2018 Dec; 32(12):4973-4979. PubMed ID: 29869086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy.
    Yan H; Wang R; Zhao F; Zhu K; Jiang S; Zhao W; Feng R
    Acta Radiol; 2011 Jul; 52(6):646-50. PubMed ID: 21508201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pragmatic staging of oesophageal cancer using decision theory involving selective endoscopic ultrasonography, PET and laparoscopy.
    Findlay JM; Bradley KM; Maile EJ; Braden B; Maw J; Phillips-Hughes J; Gillies RS; Maynard ND; Middleton MR
    Br J Surg; 2015 Nov; 102(12):1488-99. PubMed ID: 26458070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer.
    Ong LT; Dunphy M; Foster A; Woo KM; Zhang Z; Perez CA; Pietanza CM; Rosenzweig KE; Gelblum DY; Rimner A; Wu AJ
    Clin Lung Cancer; 2016 May; 17(3):184-8. PubMed ID: 26320828
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Linder G; Korsavidou-Hult N; Bjerner T; Ahlström H; Hedberg J
    Clin Radiol; 2019 Sep; 74(9):718-725. PubMed ID: 31221468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of volumetric PET parameters in unresectable and metastatic esophageal cancer.
    Tamandl D; Ta J; Schmid R; Preusser M; Paireder M; Schoppmann SF; Haug A; Ba-Ssalamah A
    Eur J Radiol; 2016 Mar; 85(3):540-5. PubMed ID: 26860665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.
    Koyasu S; Nakamoto Y; Kikuchi M; Suzuki K; Hayashida K; Itoh K; Togashi K
    AJR Am J Roentgenol; 2014 Apr; 202(4):851-8. PubMed ID: 24660716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer.
    Chung HH; Lee I; Kim HS; Kim JW; Park NH; Song YS; Cheon GJ
    Gynecol Oncol; 2013 Sep; 130(3):446-51. PubMed ID: 23791826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective comparison of MR with diffusion-weighted imaging, endoscopic ultrasound, MDCT and positron emission tomography-CT in the pre-operative staging of oesophageal cancer: results from a pilot study.
    Giganti F; Ambrosi A; Petrone MC; Canevari C; Chiari D; Salerno A; Arcidiacono PG; Nicoletti R; Albarello L; Mazza E; Gallivanone F; Gianolli L; Orsenigo E; Esposito A; Staudacher C; Del Maschio A; De Cobelli F
    Br J Radiol; 2016 Dec; 89(1068):20160087. PubMed ID: 27767330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
    Chen HH; Chiu NT; Su WC; Guo HR; Lee BF
    Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Prognostic Role of Pre-operative Positron Emission Tomography-Computed Tomography and Endoscopic Ultrasound Parameters in Oesophageal Adenocarcinoma.
    Dellaportas D; Zylstra J; Gossage J; Baker C; Kelly M; Hemelrijck MV; Griffin N; Lagergren J; Davies AR
    Chirurgia (Bucur); 2019; 114(4):443-450. PubMed ID: 31511130
    [No Abstract]   [Full Text] [Related]  

  • 35. Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from
    Kim YI; Kim YJ; Paeng JC; Cheon GJ; Lee DS; Chung JK; Kang KW
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1787-1795. PubMed ID: 28616695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of baseline FDG-PET/CT scan as a method of staging regional lymph nodes in patients with operable distal oesophageal or gastroesophageal junction adenocarcinoma.
    Papaxoinis G; Weaver JMJ; Khoja L; Patrao A; Stamatopoulou S; Alchawaf A; Owen-Holt V; Germetaki T; Kordatou Z; Mansoor W
    Acta Oncol; 2017 Sep; 56(9):1224-1232. PubMed ID: 28524708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease.
    Sihvo EI; Räsänen JV; Knuuti MJ; Minn HR; Luostarinen ME; Viljanen T; Färkkilä MA; Salo JA
    J Gastrointest Surg; 2004 Dec; 8(8):988-96. PubMed ID: 15585386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma.
    Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
    Eur J Haematol; 2015 Jun; 94(6):532-9. PubMed ID: 25311082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of Intratumoral Metabolic Heterogeneity and Quantitative
    Pinho DF; King B; Xi Y; Albuquerque K; Lea J; Subramaniam RM
    AJR Am J Roentgenol; 2020 Apr; 214(4):908-916. PubMed ID: 32069078
    [No Abstract]   [Full Text] [Related]  

  • 40. The correlation between molecular pathological profiles and metabolic parameters of
    Song J; Li Z; Chen P; Zhou N; Zhang Y; Yang Z; Wang X
    Abdom Radiol (NY); 2020 Feb; 45(2):312-321. PubMed ID: 31111196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.